Alvotech ( ALVO) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Good day, and thank you for standing by. Welcome to the Alvotech Q3 2025 Earnings Conference Call. [Operator Instructions] Please ...

Commercial litigation is notoriously expensive. It’s not unusual for a case to take years and cost hundreds of thousands of dollars in legal bills, just to get to trial. That financial barrier causes ...

‘That Has Never Been Tolerated in the Entire History of Our Republic’ Kelly Clarkson Looks Incredible (and So Different) with Short Curly Hair for Halloween 7 lions to be euthanized at wildlife park: ...

Johnson & Johnson’s JNJ multibillion-dollar immunology drug, Stelara, lost patent exclusivity in the United States this year. It is approved for treating moderate-to-severe plaque psoriasis, active ...

Live vaccines, such as those for measles, mumps, and rubella, should be avoided during Stelara treatment. This is because Stelara may weaken the immune system, leading to infection or symptoms of the ...

The MarketWatch News Department was not involved in the creation of this content. Company's third biosimilar expands access to proven targeted biologic therapy with patient-centric support services ...

RALEIGH, N.C., Aug. 18, 2025 /PRNewswire/ -- Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology ...

Mumbai isn’t just a city — it’s India’s heartbeat of business and finance. As the financial capital of India, Mumbai continues to evolve in 2022 with rising skyscrapers, massive infrastructure ...

Credit: Fresenius Kabi. The FDA originally approved Otulfi as a biosimilar in October 2024 based on clinical data that demonstrated the product was highly similar to Stelara. Patients may now switch ...

Kelvin Coleman, FAA associate administrator for commercial space transportation, at the FAA's 2024 commercial space transportation conference. Credit: SpaceNews/Jeff Foust WASHINGTON — The head of the ...